This work extends our previous finding that lymphocyte treatment with gp120 IIIB specifically induces CD4 association with several surface molecules to other molecules and to three other gp120s from different HIV-1 strains. The ability to induce this association was displayed by the four gp120s employed, i.e. gp120 IIIB , gp120 SF2 , gp120 MN and gp120 451 , and the association patterns were different, as shown by both co-capping and immunoprecipitation. Co-capping showed that all four gp120s significantly potentiated CD4 association with CD3, CD45RA, CD45RB, CD38, CD26, CD59 and class I MHC molecules. By contrast, CD4 association with CD95 was induced only by gp120 451 and gp120 MN ; that with CD11a only by gp120 SF2 and gp120 MN ; and that with CD27 and CD45RO only by gp120 MN and gp120 451 respectively. All gp120s induced significant CD4 association with CD49d, but gp120 SF2 displayed a significantly weaker effect than gp120 IIIB . Induction of association was not mediated by inside-out signaling via the CD4-associated tyrosine kinase p56 lck , since it was not inhibited by the tyrosine kinase inhibitors herbymicin and genistein, nor by CD45 bridging between CD4 and the associating molecule, since similar patterns of association were detected in cells expressing different CD45 isoform patterns. Moreover, it was not mediated by chemokine receptors interacting with the gp120 V3 loop, since RANTES did not alter the gp120-induced CD4 association pattern. By contrast, the observation that gp120s from four HIV-1 strains induce different CD4 association patterns suggests that gp120 directly interacts with the associating molecules, possibly via their hypervariable regions.
Introduction

HIV-1 infects lymphocytes via its envelope glycoprotein
HIV co-receptors. The search for these co-receptors has resulted in the identification of several candidate molecules. gp120, which is non-covalently associated with transmembrane gp41 on the virus surface (1, 2) . Different gp120 isolates
The first identified was CD26, which seems to be effective for monocytotropic HIV-1 strains (5, 6) . Other authors have since display a high degree of variability in the amino acid sequence, which preferentially involves five hypervariable regions. gp120
suggested that several chemokine receptors may be coreceptors for both monocytotropic and lymphocytotropic binds with high affinity to the lymphocyte CD4 molecule that serves as the main virus receptor. This binding triggers HIV-1 strains (7) (8) (9) . gp120 may make other contributions to the immunopathoconformational changes in the gp120-gp41 complex and promotes viral fusion with the cell membrane and entry into genesis of AIDS. Soluble gp120 released by infected cells may contribute to immunodeficiency by acting on uninfected the cell; however, CD4 expression is not in itself sufficient to allow viral entry (3, 4) . By contrast, CD4-bound HIV-1 particles cells (1) . It may sterically block the interaction of CD4 with MHC class II molecules and passively inhibit its co-receptor need to interact with other cell surface molecules serving as function in T cell activation; it may trigger negative signals cells to minimize CD45 isoform switching during the culture: 1 day in RPMI/10% FCS/1 µg/ml PHA, following by washing via CD4 and induce lymphocyte anergy or programmed cell death; it may potentiate CD4 ϩ cell depletion by targeting and culture for 2 days in RPMI/10% FCS/10 U/ml recombinant IL-2 and use in the co-capping assay. gp120-specific antibodies and cytotoxic cells against uninfected CD4 ϩ cells presenting unprocessed and processed
Physical association analysis by co-capping gp120 on their surface.
We have previously examined the possibility that gp120 Co-capping experiments were performed as previously reported on PHA-activated cells to obtain optimal capping binding to CD4 alters its lateral association with lymphocyte surface molecules and suggested that assembly of abnormal and analyze molecules expressed on cell activation (10) . Two sets of mAb were used: one was Ars-conjugated and stained multi-molecular complexes could be involved in either gp120-induced CD4 ϩ T cell dysfunction or viral entry (10) . In the with affinity-purified FITC-conjugated rabbit anti-Ars serum, the other was biotin-conjugated and stained with TRITCabsence of gp120, CD4 displayed high association with CD3, CD5, CD45RC, CD25, CD28, CD44 and CD53; low association conjugated avidin (Serotec). Cells were washed, resuspended in medium (RPMI/10% FCS) and treated with a saturating with CD2, CD38, CD45RB, CD62L and CD26; and no association with CD45RA, CD45RO, CD11b, CD11a, CD54, CD7, concentration (10 µg/ml) of recombinant gp120 IIIB (Intracell, London, UK), recombinant gp120 SF2 (generous gift from CD48, CD98, CD59, CD55, and HLA class I and class II molecules. Treatment with gp120 significantly increased CD4
Chiron, Emeryville, CA), recombinant gp120 MN (Agmed, Bedford, MA), affinity-purified gp120 451 (ABI, Columbia, ML) association with CD3, CD45RA, CD45RB, CD59, CD38, CD26 and HLA class I, and decreased that with CD45RC. This or with an equal volume of PBS (control cells) at 37°C for 30 min. Saturating amounts of the Ars-conjugated OKT4 mAb, study extends the analysis to other molecules and investigates the mechanism that could be responsible for the associations which binds to a different CD4 epitope than gp120, were then added and incubation was continued at 4°C for a further induced by gp120.
30 min. Cells were washed with cold medium and stained at 4°C for 30 min with the FITC-conjugated anti-Ars serum, Methods incubated for 20 min at 37°C to induce capping, washed with ice-cold PBS/5% FCS/0.1% NaN 3 to stop capping, stained at mAb 4°C in 0.1% NaN 3 with the biotin-conjugated mAb, followed mAb included OKT3 (CD3), OKT8 (CD8), OKT4 (CD4) and by TRITC-conjugated avidin, fixed with paraformaldehyde OKM1 (CD11b) (ATCC, Rockville, MD); UCHL1 (CD45RO) and analyzed with a fluorescence microscope by a 'blind' and PD7/26 (CD45RB) (Dako Immunoglobulins, Copenhagen, observer. Cells that presented a FITC staining limited to less Denmark); ALB-11 (CD45RA), UB2 (CD95) and VLA-4 then one-third of the membrane were regarded as 'capping' (CD49d) (Immunotech, Marseilles, France); MCA347 cells and at least 200 were counted for each sample. 'Co-(CD45RC), MCA755 (CD27) and CD62L (Serotec, Oxford, capping' was defined as a co-localization of the TRITC UK); Leu3 (CD4), Leu28 (CD28), Leu9 (CD7) and Leu8 staining in the area of the cap. In some experiments, CD4 ϩ (CD62L) (Becton Dickinson, Mountain View, CA); Ta1 (CD26) lines were treated or not with the tyrosine kinase inibitors (Eurogenetics, Tessenderlo, Belgium). IB4 (CD38), CBT11 herbymicin (25 µM for 18 h) and genistein (100 µM for 90 (CD2), CB01 (CD5), CB39 (CD25), CB05 (CD44), CB13 (HLA min) (Sigma, St Louis, MO) or with the chemokine RANTES class II), AB6.60 (HLA class I), NO.11a (CD11a), NO.59 (1 µg/ml for 30 min) (Immunokontact, Frankfurt, Germany). (CD59) and Moon-1 (CD31) were locally produced. Treatment with gp120 and CD4 co-capping were then per-(CD48) mAb was kindly donated by Dr V. Horejsi (Institute of formed as described above in the presence of the inhibitor Molecular Genetics, Prague, Czech Republic). mAb were or the chemokine. purified by affinity chromatography with Protein G-Sepharose
Immunoprecipitation assay and in vitro kinase assay (Pharmacia, Uppsala, Sweden) and conjugated with arsonate (Ars) or biotin, as previously reported.
Cells were surface labeled by lactoperoxidase/H 2 O 2 catalyzed iodination, washed, resuspended in medium (RPMI/ Cells 10% FCS) and treated with saturating concentrations of gp120 at 37°C for 30 min. They were then lysed on ice with Peripheral blood mononuclear cells were prepared by gradient centrifugation (Lymphoprep; Nycomed, Oslo, 10 mM CHAPS (3-[(3-cholamidopropyl)-dimethylammonio]-1-propanesulfonate) (Pierce Europe, Oud-Beijerland, The Norway) of buffy coats obtained from the local blood bank. Monocytes were removed by plastic adherence. CD4 ϩ T cells Netherlands) in 50 mM Tris (pH 7.5), 300 mM NaCl, 1 mM phenylmethylsulfonyl fluoride (PMSF) and 10 µg/ml aprotinin were then purified as CD8 -CD11b -HLA class II -cells by panning. Their purity was Ͼ85%, as assessed by direct (lysis buffer). Lysates were centrifuged in a microcentrifuge at 4°C for 30 min and cleared using mouse Ig-Sepharose. immunofluorescence and FACS analysis (Becton Dickinson). CD4 ϩ T cells were cultured for 2 days in RPMI/10% FCS/ Lysate aliquots were incubated for 3 h with Protein GSepharose pretreated with the appropriate mAb, washed 1 µg/ml phytohemagglutinin (PHA), washed and cultured for 3 days in RPMI/10% FCS/10 U/ml recombinant IL-2 and used twice with lysis buffer, eluted with 2ϫsample buffer (125 mM Tris, 29% glycerol, 4.6% SDS and 10% mercaptoethanol), in the co-capping or immunoprecipitation assays. CD45RA -CD45RO ϩ and CD45RO -CD45RA ϩ CD4 ϩ subsets purified separated by electrophoresis on a 5-17% gradient polyacrylamide gel and visualized using a Phosphor Imager from CD4 ϩ T cell preparations by panning (purity was Ͼ80%) were cultured for shorter times than unfractionated CD4 ϩ T (BioRad, Hercules, CA).
( Fig. 1 ). By contrast, gp120 IIIB had only a slight effect on the pattern of molecules co-precipitating with the control molecules CD11a ( Fig. 1 ) and class II MHC (data not shown).
One explanation of these data could be that the molecular associations were induced by inside-out signaling triggered via the CD4-associated tyrosine kinase p56 lck by gp120 (11) . To assess this possibility, we used the co-capping technique to evaluate the effect of the tyrosine kinase inhibitors herbymicin and genistein on the gp120-induced CD4 lateral associations. Moreover, we extended the co-capping analysis to the adhesion molecules CD31, CD43 and CD49d, the tumor necrosis factor receptor-like molecules CD27 and CD95, and CD71. These experiments confirmed the previously reported data that gp120 IIIB potentiates CD4 association with CD3, CD45RA, CD45RB, CD26, CD38, CD59 and class I MHC molecules, and showed that it also potentiates CD4 association with CD49d (Tables 1 and 3 ). However, signaling via patterns of CD45 isoforms, i.e. peripheral blood CD4 ϩ CD45RO low (naive) and CD4 ϩ CD45RA low (memory/activated) T cells (14) . These cells were purified by panning and cultured with PHA ϩ IL-2 for 3 days. Lines derived from 'naive' cells In the in vitro kinase assay, unlabeled cells were treated with gp120 as reported above and lysed for 15 min on ice expressed high levels of CD45RA, CD45RB and CD45RC, and low levels of CD45RO, whereas those derived from with lysis buffer plus 1 mM sodium orthovanadate. Preclearing and immunoprecipitation were performed as described 'memory' cells expressed the opposite phenotype. In the absence of gp120, 'memory' cells displayed higher CD4 above. The immunoprecipitates were washed five times with 2 mM CHAPS in 50 mM Tris (pH 7.5), 300 mM NaCl, 1 mM association with CD3, CD11a and CD26, and lower association with CD49d than 'naive' cells, whereas in its presence the PMSF, 10 µg/ml aprotinin and 1 mM sodium orthovanadate (washing buffer). Kinase assays were performed by addition lateral association pattern was similar in both cell lines (Table 2) . to washed immunoprecipitates of 50 µl of kinase buffer [2 mM CHAPS in 25 mM HEPES (pH 7.2), 10 mM MgCl 2 3 mM MnCl 2 A further possibility was that the associations were mediated by gp120 bridging between CD4 and the associating moleand 200 µM sodium orthovanadate] and 10 µCi [γ-32 P]ATP (3000 Ci/mmol; 1 Ci ϭ 37 GBq; Amersham, Amersham, UK).
cule. Since gp120s derived from different HIV-1 strains display high variability in their amino acid sequence, their ability to After incubation for 20 min at 25°C, the reaction was stopped by addition of 1 ml of washing buffer and centrifugation. Then, bridge may differ. We therefore analyzed the CD4 lateral association pattern induced by gp120 IIIB , gp120 SF2 , gp120 MN samples were eluted, separated on 12% polyacrylamide gel and visualized using a Phosphor Imager. and gp120 451 by co-capping (Table 3 ). All four gp120s significantly potentiated CD4 association with CD3, CD45RA, CD45RB, CD38, CD26 and CD59, and inhibited CD4 associResults ation with CD45RC. The effect of gp120 SF2 , gp120 MN and gp120 451 was not significantly different than of gp120 IIIB , used In a previous study, we used the co-capping technique to show that lymphocyte treatment with gp120 IIIB specifically as the reference gp120 for the statistical analysis. By contrast, the effect on associations with CD49d, CD95, CD27, CD45RO induced CD4 association with several molecules (10) . To confirm these data, we analyzed CD4 association with surface and CD11a was dependent on the gp120 type: association with CD95 was induced by gp120 451 and, at lower levels, molecules by immunoprecipitation. CD4 was immunoprecipitated from 125 I-surface-labeled CD4 ϩ T cells treated or not gp120 MN , and not by gp120 IIIB and gp120 SF2 ; association with CD11a was induced by gp120 SF2 and gp120 MN but with gp120 IIIB and lysed with the mild detergent CHAPS to preserve intermolecular associations. Analysis of the immunonot by gp120 IIIB and gp120 451 ; association with CD27 and CD45RO was only induced by gp120 MN and gp120 451 precipitated material separated by SDS-PAGE showed that cell treatment with gp120 IIIB altered the pattern of molecules respectively. Moreover, all gp120s induced significant CD4 association with CD49d, but the effect displayed by gp120 SF2 precipitating with CD4, and induced or potentiated precipitation of bands at~174, 74, 56, 50, 42, 28-32 and 10-15 kDa was significantly weaker than that of gp120 IIIB . was assessed by co-capping ( cyte treatment with gp120 alters the pattern of CD4 association with surface molecules. It shows that the ability to induce this association (i) is displayed by gp120s derived from different HIV-1 strains; (ii) can be detected both by co-capping and To confirm that gp120s derived from different HIV-1 strains induce different patterns of CD4 lateral associations, CD4 was immunoprecipitation; (iii) is not mediated either by signaling via the CD4-associated tyrosine kinase p56 lck nor by CD45 immunoprecipitated from lymphocytes treated with gp120 IIIB , gp120 SF2 , gp120 MN or gp120 451 and in vitro kinase assays bridging between CD4 and the associating molecule; and (iv) is not modulated by chemokines that bind the viral cowere performed on the precipitated material. This approach has been reported to be highly sensitive in detection of lateral receptors CCR3 and CCR5. Moreover, it reports gp120-induced CD4 associations not detected in the previous work, associations (15) . Figure 2 shows that this induced different precipitation patterns: gp120 IIIB induced preferential coi.e. those with CD49d, CD11a, CD45RO, CD27 and CD95, and shows that the association patterns are partly dependent precipitation of bands at~104, 74, 50, 44 and 20-22 kDa, gp120 SF2 at 44 kDa, gp120 MN at 96 kDa, and gp120 451 at on the HIV-1 strain from which a gp120 is derived. The gp120 effect on CD4 lateral associations is specific, 114 and 50 kDa. The total amount of kinase activity precipitating with CD4 was strikingly higher in untreated than in gp120-since it did not affect the pattern of those displayed by control several interpretations, i.e. (i) gp120-CD4 interaction triggers inside-out signaling responsible for the associations, (ii) the associating molecules may interact with third-player molecules bridging between them and gp120, and (iii) they may directly interact with gp120 bridging between them and CD4. These possibilities are not mutually exclusive and may play different roles in each association. The observation that cell treatment with tyrosine kinase inhibitors did not affect the gp120-induced CD4 lateral associations suggests that inside-out signaling via p56 lck plays a marginal role. However, gp120-triggered CD4 signaling through p56 lck -independent pathways cannot be ruled out. This possibility has been suggested for IL-16, which triggers chemotactical signals via CD4 that are not affected by tyrosine kinase inhibitors (18, 19) . A minor role for inside-out signaling is also suggested by the observation that the Leu3 mAb, which binds CD4 on a site overlapping the gp120 binding immunoprecipitation (e) was performed using the 2D12 anti-CD11a
Our previous work indicated that the gp120-induced CD4 mAb on cells treated with gp120 IIIB . One experiment representative from four experiments. Arrows indicate the bands whose precipitation association with CD59 might be mediated by complement with CD4 is induced or potentiated by cell treatment with each gp120.
components binding both CD59 and gp120 (10) . In the present work, we evaluated the possibility that CD45 is the third player for some associating molecules. CD45 associates molecules, as shown both by co-capping and immunoprecipitwith several surface molecules (i.e. CD2, CD4, CD26, CD28 ation: treatment with gp120 did not alter the pattern of and CD73) in an isoform-specific manner (12, 13) . Since molecules co-capping with class II MHC molecules (10 and treatment with gp120 alters the pattern of CD45 isoforms data not shown) nor that of bands co-precipitating with CD11a associating with CD4 by inducing CD4 association with CD45RA, CD45RB and CD45RO, and inhibiting that with and class II MHC molecules. These results were open to 
a Results are expressed as percent of capping cells displaying co-capping and represent mean Ϯ SD from three experiments.
CD45RC, some molecules could be drawn into the complex on lymphocyte function. Alteration of the CD4-associated signal transduction machinery is suggested by the in vitro by the new CD45 isoform. This possibility was found to be unlikely, since cell lines expressing different CD45 isoform kinase experiments showing that gp120 alters the pattern of substrates phosphorylated by the CD4-associated kinases. patterns displayed similar CD4 association patterns.
Choe et al. reported that the β-chemokine receptors CCR3 By altering the balance between activating and apoptotic signals, gp120 may affect the T cell response and the rate of and CCR5 facilitate infection by several primary HIV-1 isolates, and that utilization of CCR3 and CCR5 on the target cell cells undergoing apoptosis. CD4 ϩ T cells from AIDS patients display accelerated apoptosis (28). This may be due to CD4 depends on the sequence of the third variable (V3) region of gp120 (8) . These findings suggest that chemokine receptors cross-linking by gp120 (29) , which sensitizes T cells to CD95-mediated apoptosis (30). It is noteworthy that we found that may be involved in the gp120-induced CD4 lateral associations. This possibility was found unlikely, since RANTES, CD4 association with CD95 was differentially induced by different gp120s. This may account for the finding by Gulizia which binds CCR3 and CCR5, and inhibits infectivity of HIV MN and not HIV IIIB , did not inhibit the CD4 lateral associations et al. that the gp120 gene determines the rate of CD4 ϩ T cell depletion in HIV-1-infected SCID mice engrafted with human induced by gp120 derived from these HIV strains. gp120 is highly variable from one HIV-1 strain to another. peripheral blood leukocytes (31). The CD4 association pattern induced by different gp120s The observation that gp120s derived from different HIV-1 strains induce different CD4 association patterns suggests may play a role in the clinical and biological differences displayed by HIV strains. Rates of AIDS development and/or that gp120 directly interacts with the associating molecules. This possibility is likely for CD11a, CD49d, CD27, CD95 and CD4 ϩ T cell depletion are highly variable in HIV-1-infected individuals and some of this variability may be due to gp120 CD45RO, whose association with CD4 is differentially affected by different gp120s and therefore probably involves hypervariitself, since its variability is sufficient to influence a virus-tocell fusion at the virus/cell entry (1). It is noteworthy that our able gp120 regions. By contrast, CD4 associations induced by several gp120s may involve more conserved regions. four gp120s were derived from syncitium-inducing HIV-1 strains (32-34), and induced aggregation of the adhesion The gp120-induced CD4 associations involve molecules playing a role in either the activation/inactivation process of molecules CD38 and CD49d. Moreover, gp120 MN and gp120 SF2 also induced aggregation of CD11a. It may be lymphocytes or in lymphocyte adhesion. CD3 and CD45 are needed for T cell activation by antigen, but may also transduce postulated that aggregation of adhesion molecules, which can potentiate cell adhesivity (35), might modulate viral apoptotic signals under certain conditions (20-22). CD95 ligation induces lymphocyte programmed cell death in activcapacity to induce syncitia, which seems to be controlled by several gp120 variable domains. This hypothesis needs furated T cells, whereas it is co-stimulatory in resting T cells (23). CD26, CD38, CD27, CD59, CD11a and CD49d transduce ther investigation comparing the effect displayed by gp120s derived from syncitium-inducing and non-syncitium-inducing signals that potentiate signaling via the TCR, and may antagonize programmed cell death induction (24) (25) (26) (27) . The HIV strains. function of these molecules may be modulated by intermolecular aggregation. CD4 association with the TCR and CD45, for example, switches its function from cell inactivation
